Meanwhile, the PLEASe Study (NCT03869073), Treatment of Severe Infection With Antihyperlipidemia Drug (NCT03634293), and PALMS (NCT05469347), are aiming to ascertain if quick bacterial component removal via PCSK9 neutralization with Evolocumab or Alirocumab proves beneficial. The gene discussed is PCSK9; the disease is infection.